General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amgen(MODEST), CSI(SIGNIFICANT), Elsevier(SIGNIFICANT), Medtronic(SIGNIFICANT), Abbott Vascular(SIGNIFICANT), Asahi(MODEST), Boston Scientific(SIGNIFICANT), IMDS(SIGNIFICANT), Terumo(MODEST), GE Healthcare(MODEST) SPEAKER'S BUREAU: Teleflex(MODEST), Biotronik(MODEST), Siemens(MODEST), Abbott Vascular(SIGNIFICANT), Asahi Intecc(MODEST) EQUITY INTERESTS/STOCK OPTIONS: MHI Ventures(NONE), Cleerly Health(NONE), Stallion Medical(NONE) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Hippocrates LLC(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Boston Scientific(SIGNIFICANT), GE Healthcare(SIGNIFICANT)

View Full Disclosure